Market News & Trends
Particle Sciences Expands cGMP Capabilities With Addition of Thin Films
Particle Sciences recently announced it has added new coating capabilities for preparing polymer film"based drug products from liquid formulations, under cGMPs. According to Garry Gwozdz,…
Protalix Biotherapeutics Gets $25-Million Milestone Payment
Protalix BioTherapeutics, Inc. recently announced it has received a $25-million milestone payment from Pfizer Inc. as part of the companies' global commercial agreement for ELELYSO…
6/6/2012
Royer Biomedical Receives Approval to Test Polymer Delivery System Royer Biomedical, Inc. (RBI) recently announced it received FDA approval to proceed with human testing of…
Bayer HealthCare & Covance Form Strategic Partnership
Bayer HealthCare and Covance Inc. recently announced they have decided to establish a long-term strategic partnership in the area of clinical drug development, including R&D…
Catalent to Sell Commercial Packaging Operations
Catalent Pharma Solutions recently signed a definitive agreement to sell its US commercial packaging operations based in Philadelphia, PA, and Woodstock, IL, to a company…
JHP Pharmaceuticals to Produce Clinical & Commercial Supply of an Innovative Injectable
JHP Pharmaceuticals recently announced it has entered into an agreement with an undisclosed pharmaceutical company to produce clinical and commercial supply of an innovative injectable…
New Clinical Trial Design Promises to Accelerate Approvals
The Food and Drug Administration (FDA) has drafted a regulatory guidance describing a new way of conducting breast cancer drug trials that promises to reduce…
Royer Biomedical Receives Approval to Test Polymer Delivery System
Royer Biomedical, Inc. (RBI) recently announced it received FDA approval to proceed with human testing of AppliGel-G (Gentamicin) in management of diabetic foot ulcers (DFU).…
Scientists Restore Full Movement to Paralysed Rats
Gregoire Courtine and his team at Ecole Polytechnique Federale de Lausanne saw rats with severe paralysis walking and running again after a couple of weeks…
Zurex Pharma Inc. Secures $6.2-Million Financing
Zurex Pharma, Inc. recently announced it has raised $6.2 million in Series A financing, led by Baird Venture Partners and the State of Wisconsin Investment…
5/30/2012
Takeda's MAA Filing Triggers a $10-Million MilestoneFuriex Pharmaceuticals, Inc. recently confirmed that Takeda Global Research & Development Centre (Europe) Ltd. received confirmation on the acceptance…
Bend Research Increases Hot-Melt Extrusion Capacity
Bend Research Inc. recently announced the expansion of its existing hot-melt extrusion (HME) capacity with the addition of an 18-mm Leistritz twin-screw mixer/extruder. The 18-mm…
CLINiLABS Opens Phase I Unit
Clinilabs, an early phase and specialty CRO that provides clinical drug development services to the pharmaceutical industry, recently announced it has opened a second Phase…
Royalty Pharma Raises $600 Million of Debt
Royalty Pharma recently announced it has successfully issued $600 million of incremental Term Loan B debt through RPI Finance Trust (RPIFT), bringing total debt outstanding…
Takeda's MAA Filing Triggers a $10-Million Milestone
Furiex Pharmaceuticals, Inc. recently confirmed that Takeda Global Research & Development Centre (Europe) Ltd. received confirmation on the acceptance of the submission of a Marketing…
Tranzyme Pharma & Norgine Announce Top-Line Data
Tranzyme Pharma and Norgine B.V. recently announced top-line results of the primary analysis of ULISES 008, the second of two Phase III pivotal trials evaluating…
5/23/2012
Agilent to Acquire Cancer Diagnostic Company for $2.2 Billion Agilent Technologies Inc. and EQT, the Sweden-based private equity group, recently announced the execution of a…
Agilent to Acquire Cancer Diagnostic Company for $2.2 Billion
Agilent Technologies Inc. and EQT, the Sweden-based private equity group, recently announced the execution of a definitive agreement for Agilent to acquire Dako, the Denmark-based…
IntelliCap Provides Reliable & Accurate Delivery
Medimetrics, recently certified to ISO 13485, has successfully developed the IntelliCap system, specifically designed to target delivery of small molecule drugs and biologics to the…
Newron & Zambon Enter Strategic Collaboration & License Agreement
Newron Pharmaceuticals S.p.A. recently announced it has executed with Zambon a strategic collaboration and license agreement for Newron's lead compound safinamide. In aggregate, the total…